First gene therapy to go on sale in 2013

c gene therapy conc

The first gene therapy to be approved in a regulated market was announced by the European Commission, which granted its approval to a treatment for the rare inherited disorder lipoprotein lipase deficiency (LPL). This genetic disorder leaves people unable to store fat in adipose and muscle cells. The new drug has been named Glybera by its maker, UniQure. The therapy, which manufacturers say will be available next year, uses a virus to insert a working copy of the gene into muscle.

Related Articles:

 

View the original article here: http://www.bbc.co.uk/news/health-20179561

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend